Be Aware of the Role of Pharmacogenetic Testing for Mental Health Conditions

October 2018

You'll hear debate about using pharmacogenetic testing to guide treatment for depression, ADHD, and other mental health conditions.

The goal of testing is to identify gene variations that may predict how a patient responds to certain meds.

For example, patients who are ultrarapid CYP2C19 metabolizers may have lower blood levels of citalopram...and poor CYP2D6 metabolizers may have higher blood levels of atomoxetine (Strattera).

Get concise advice on drug therapy, plus unlimited access to CE

Hospital Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote